المؤلفون: Labori, Knut Jørgen, Bratlie, Svein Olav, Andersson, Bodil, Angelsen, Jon-Helge, Biörserud, Christina, Björnsson, Bergthor, Bringeland, Erling Audun, Elander, Nils, Garresori, Herish, Grønbech, Jon Erik, Haux, Johan, Hemmingsson, Oskar, Liljefors, Maria Gustafsson, Myklebust, Tor Åge, Nymo, Linn Såve, Peltola, Katriina, Pfeiffer, Per, Sallinen, Ville, Sandström, Per, Sparrelid, Ernesto, Stenvold, Helge, Søreide, Kjetil, Tingstedt, Bobby, Verbeke, Caroline, Öhlund, Daniel, Klint, Leif, Dueland, Svein, Lassen, Kristoffer, Mortensen, Michael Bau

المصدر: Labori , K J , Bratlie , S O , Andersson , B , Angelsen , J-H , Biörserud , C , Björnsson , B , Bringeland , E A , Elander , N , Garresori , H , Grønbech , J E , Haux , J , Hemmingsson , O , Liljefors , M G , Myklebust , T Å , Nymo , L S , Peltola , K , Pfeiffer , P , Sallinen , V , Sandström , P , Sparrelid , E , Stenvold , H , Søreide , K , Tingstedt , B , ....

مصطلحات موضوعية: Humans, Irinotecan/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Pancreatic Neoplasms/drug therapy, Oxaliplatin/therapeutic use, Leucovorin/adverse effects, Neoadjuvant Therapy/adverse effects, Capecitabine, Gemcitabine, Adenocarcinoma/drug therapy, Fluorouracil/adverse effects, Carcinoma, Pancreatic Ductal/drug therapy

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/893612f8-7208-4f68-ac90-bc1b6ce3bcb3Test

الإتاحة: https://doi.org/10.1016/S2468-1253Test(23)00405-3
https://portal.findresearcher.sdu.dk/da/publications/893612f8-7208-4f68-ac90-bc1b6ce3bcb3Test

المساهمون: Hyehyun Jeong, Yong Sang Hong, Jeong Eun Kim, Hyeong-Seok Lim, Joong Bae Ahn, Sang Joon Shin, Young Suk Park, Seung Tae Kim, Sae-Won Han, Tae-You Kim, Tae Won Kim, Shin, Sang Joon

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents / administration & dosage, Antineoplastic Agents / adverse effects, Antineoplastic Agents / pharmacokinetics, Antineoplastic Agents / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Area Under Curve, Benzophenones / administration & dosage, Benzophenones / adverse effects, Benzophenones / pharmacokinetics, Benzophenones / therapeutic use, Colorectal Neoplasms / drug therapy, Colorectal Neoplasms / pathology, Dose-Response Relationship, Drug, Female, Half-Life, Humans, Irinotecan / therapeutic use, Kaplan-Meier Estimate, Male, Maximum Tolerated Dose, Metabolic Clearance Rate, Middle Aged, Neoplasm Metastasis, Progression-Free Survival, Valine / administration & dosage, Valine / adverse effects, Valine / analogs & derivatives

العلاقة: INVESTIGATIONAL NEW DRUGS; J01184; OAK-2022-04835; OAK-2022-04836; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190746Test; https://link.springer.com/article/10.1007/s10637-021-01110-9Test; T9992022153; INVESTIGATIONAL NEW DRUGS, Vol.39(5) : 1335-1347, 2021-10

الإتاحة: https://doi.org/10.1007/s10637-021-01110-9Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190746Test

المؤلفون: Craig, Zoe, Swain, Jayne, Batman, Emma, Wadsley, Jonathan, Reed, Nicholas, Faluyi, Olusola, Cave, Judith, Rohini, Sharma, Chau, Ian, Wall, Lucy, Lamarca, Angela, Hubner, Richard, Mansoor, Wasat, Sarker, Debashis, Meyer, Tim, Cairns, David A., Howard, Helen, Valle, Juan, Mcnamara, Mairead

المصدر: Craig , Z , Swain , J , Batman , E , Wadsley , J , Reed , N , Faluyi , O , Cave , J , Rohini , S , Chau , I , Wall , L , Lamarca , A , Hubner , R , Mansoor , W , Sarker , D , Meyer , T , Cairns , D A , Howard , H , Valle , J & Mcnamara , M 2020 , ' NET-02 trial protocol : A multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and ....

مصطلحات موضوعية: Neuroendocrine carcinoma, randomised, single-stage, liposomal irinotecan, docetaxel, Humans, Irinotecan/therapeutic use, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Docetaxel/therapeutic use, Fluorouracil/therapeutic use, Multicenter Studies as Topic, Carcinoma, Neuroendocrine/drug therapy, Quality of Life, Clinical Trials, Phase II as Topic, Leucovorin/therapeutic use, ResearchInstitutes_Networks_Beacons/mcrc, Manchester Cancer Research Centre

الإتاحة: https://doi.org/10.1136/bmjopen-2019-034527Test
https://research.manchester.ac.uk/en/publications/3e3acd38-1452-45c5-bc7c-2c1e3a9d7e80Test
http://www.scopus.com/inward/record.url?scp=85079084289&partnerID=8YFLogxKTest
https://www.mendeley.com/catalogue/6f29ece9-cc63-3686-a0e4-3343b118dc3bTest/

المؤلفون: Kopetz, Scott, Grothey, Axel, Yaeger, Rona, Van Cutsem, Eric, Desai, Jayesh, Yoshino, Takayuki, Wasan, Harpreet, Ciardiello, Fortunato, Loupakis, Fotios, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod K., Arkenau, Hendrik Tobias, Garcia-Alfonso, Pilar, Pfeiffer, Per, Orlov, Sergey, Lonardi, Sara, Elez, Elena, Kim, Tae Won, Schellens, Jan H.M., Guo, Christina, Krishnan, Asha, Dekervel, Jeroen, Morris, Van, Ferrandiz, Aitana Calvo, Tarpgaard, L. S., Braun, Michael, Gollerkeri, Ashwin, Keir, Christopher, Maharry, Kati, Pickard, Michael, Christy-Bittel, Janna, Anderson, Lisa, Sandor, Victor, Tabernero, Josep

المصدر: Kopetz , S , Grothey , A , Yaeger , R , Van Cutsem , E , Desai , J , Yoshino , T , Wasan , H , Ciardiello , F , Loupakis , F , Hong , Y S , Steeghs , N , Guren , T K , Arkenau , H T , Garcia-Alfonso , P , Pfeiffer , P , Orlov , S , Lonardi , S , Elez , E , Kim , T W , Schellens , J H M , Guo , C , Krishnan , A , Dekervel , J , ....

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Benzimidazoles/administration & dosage, Carbamates/administration & dosage, Cetuximab/administration & dosage, Colorectal Neoplasms/drug therapy, Disease Progression, Electrocorticography, Female, Humans, Intention to Treat Analysis, Irinotecan/therapeutic use, Kaplan-Meier Estimate, Male, Middle Aged, Mutation, Proto-Oncogene Proteins B-raf/genetics, Sulfonamides/administration & dosage, Survival Analysis

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/2010050b-824d-4aab-9a84-975886e3de54Test

الإتاحة: https://doi.org/10.1056/NEJMoa1908075Test
https://portal.findresearcher.sdu.dk/da/publications/2010050b-824d-4aab-9a84-975886e3de54Test
https://findresearcher.sdu.dk/ws/files/158747483/nejmoa1908075.pdfTest

المؤلفون: Lilly J H Brada, Quintus Molenaar, Koop Bosscha, Ronald M. van Dam, Ignace H. J. T. de Hingh, Vincent E de Meijer, Frank J. Wessels, Sebastiaan Festen, Yung C Nio, Lisa G Magermans, Jan J. J. de Vries, Rutger C G Bruijnen, Marco B. Polee, Krijn P van Lienden, Mike S L Liem, Olivier R. Busch, Lois A. Daamen, Hjalmar C. van Santvoort, Marc G. Besselink, Casper H.J. van Eijck, Gijs A. Patijn, Martijn W J Stommel, Hanneke Wilmink, Bas Groot Koerkamp, M.S. Walma, Diba Latifi

المساهمون: Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Surgery, Radiology and Nuclear Medicine, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie

المصدر: Annals of Surgery, 274(5), 729-735. LIPPINCOTT WILLIAMS & WILKINS
Annals of surgery, 274(5), 729-735. Lippincott Williams and Wilkins
Annals of Surgery, 274, 729-735
Annals of Surgery, 274(5), 729-735. Lippincott Williams & Wilkins
Annals of Surgery, 274, 5, pp. 729-735

مصطلحات موضوعية: Male, Oxaliplatin/therapeutic use, FOLFIRINOX, SURGERY, IMPACT, Leucovorin, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], QUALITY-OF-LIFE, Antineoplastic Combined Chemotherapy Protocols, Medicine, Prospective Studies, resection, Prospective cohort study, Netherlands, BORDERLINE, Survival Rate/trends, OUTCOMES, Leucovorin/therapeutic use, Hazard ratio, Middle Aged, locally advanced pancreatic cancer, Oxaliplatin, Survival Rate, Pancreatectomy/methods, Response Evaluation Criteria in Solid Tumors, Cohort, Female, Fluorouracil, medicine.medical_specialty, Irinotecan/therapeutic use, Urology, Antineoplastic Agents, Netherlands/epidemiology, Pancreas/pathology, Irinotecan, Fluorouracil/therapeutic use, Pancreatectomy, SDG 3 - Good Health and Well-being, Humans, Pancreatic Neoplasms/diagnosis, Propensity Score, Pancreas, NEOADJUVANT THERAPY, Neoplasm Staging, business.industry, Proportional hazards model, Antineoplastic Agents/therapeutic use, ADENOCARCINOMA, Confidence interval, Pancreatic Neoplasms, Propensity score matching, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ef9fb25d1e317bffbe82956feddc65Test
https://research.rug.nl/en/publications/879dd244-9b84-48da-b3fe-2dc2b8df7b87Test

المؤلفون: Axel Grothey, Sara Lonardi, Victor Sandor, Neeltje Steeghs, Rona Yaeger, Elena Elez, Yong Sang Hong, Harpreet Wasan, Christina Guo, Jan H.M. Schellens, Tae Won Kim, Eric Van Cutsem, Ashwin Gollerkeri, Tormod Kyrre Guren, Fotios Loupakis, Line Schmidt Tarpgaard, Kati Maharry, Jayesh Desai, Lisa Anderson, Sergey Orlov, Aitana Calvo Ferrándiz, Jeroen Dekervel, Michael Braun, Per Pfeiffer, Asha Krishnan, Pilar García-Alfonso, Michael D Pickard, Scott Kopetz, Janna Christy-Bittel, Hendrik Tobias Arkenau, Takayuki Yoshino, Fortunato Ciardiello, Christopher Hunt Keir, Van Morris, Josep Tabernero

المساهمون: Kopetz, Scott, Grothey, Axel, Yaeger, Rona, Van Cutsem, Eric, Desai, Jayesh, Yoshino, Takayuki, Wasan, Harpreet, Ciardiello, Fortunato, Loupakis, Fotio, Hong, Yong Sang, Steeghs, Neeltje, Guren, Tormod K, Arkenau, Hendrik-Tobia, Garcia-Alfonso, Pilar, Pfeiffer, Per, Orlov, Sergey, Lonardi, Sara, Elez, Elena, Kim, Tae-Won, Schellens, Jan H M, Guo, Christina, Krishnan, Asha, Dekervel, Jeroen, Morris, Van, Calvo Ferrandiz, Aitana, Tarpgaard, L S, Braun, Michael, Gollerkeri, Ashwin, Keir, Christopher, Maharry, Kati, Pickard, Michael, Christy-Bittel, Janna, Anderson, Lisa, Sandor, Victor, Tabernero, Josep

المصدر: Kopetz, S, Grothey, A, Yaeger, R, Van Cutsem, E, Desai, J, Yoshino, T, Wasan, H, Ciardiello, F, Loupakis, F, Hong, Y S, Steeghs, N, Guren, T K, Arkenau, H T, Garcia-Alfonso, P, Pfeiffer, P, Orlov, S, Lonardi, S, Elez, E, Kim, T W, Schellens, J H M, Guo, C, Krishnan, A, Dekervel, J, Morris, V, Ferrandiz, A C, Tarpgaard, L S, Braun, M, Gollerkeri, A, Keir, C, Maharry, K, Pickard, M, Christy-Bittel, J, Anderson, L, Sandor, V & Tabernero, J 2019, ' Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer ', New England Journal of Medicine, vol. 381, no. 17, pp. 1632-1643 . https://doi.org/10.1056/NEJMoa1908075Test

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Irinotecan/therapeutic use, Colorectal cancer, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Carbamates/administration & dosage, Internal medicine, Encorafenib, Proto-Oncogene Proteins B-raf/genetics, medicine, Humans, 030212 general & internal medicine, Benzimidazoles/administration & dosage, Survival analysis, Aged, Cetuximab/administration & dosage, Aged, 80 and over, Sulfonamides/administration & dosage, Cetuximab, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Colorectal Neoplasms/drug therapy, Binimetinib, General Medicine, Middle Aged, medicine.disease, Survival Analysis, digestive system diseases, Intention to Treat Analysis, BRAF V600E, Irinotecan, Clinical trial, chemistry, Mutation, Disease Progression, Female, Electrocorticography, business, medicine.drug

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ce4d5efea909032075f515edc5b20aTest
https://doi.org/10.1056/nejmoa1908075Test

المؤلفون: Dutch Pancreatic Cancer Group

المساهمون: Zorgeenheid Vaatchirurgie Zorg, MS CGO, Cancer, Trialbureau Beeld, MS Radiologie, Other research (not in main researchprogram), MS HOD

مصطلحات موضوعية: Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, FOLFIRINOX, Female, Fluorouracil/therapeutic use, Follow-Up Studies, Humans, Irinotecan/therapeutic use, Leucovorin/therapeutic use, Male, Middle Aged, Neoplasm Staging, Netherlands/epidemiology, Oxaliplatin/therapeutic use, Pancreas/pathology, Pancreatectomy/methods, Pancreatic Neoplasms/diagnosis, Propensity Score, Prospective Studies, Survival Rate/trends, locally advanced pancreatic cancer, resection, Surgery, Multicenter Study, Journal Article

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/444533Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/444533Test

المؤلفون: Brada, Lilly J H, Daamen, Lois A, Magermans, Lisa G, Walma, Marieke S, Latifi, Diba, van Dam, Ronald M, de Hingh, Ignace H, Liem, Mike S L, de Meijer, Vincent E, Patijn, Gijs A, Festen, Sebastiaan, Stommel, Martijn W J, Bosscha, Koop, Polée, Marco B, Nio, Yung C, Wessels, Frank J, de Vries, Jan J J, van Lienden, Krijn P, Bruijnen, Rutger C, Busch, Olivier R, Koerkamp, Bas Groot, van Eijck, Casper, Molenaar, Quintus I, Wilmink, Hanneke J W, van Santvoort, Hjalmar C, Besselink, Marc G

المصدر: Brada , L J H , Daamen , L A , Magermans , L G , Walma , M S , Latifi , D , van Dam , R M , de Hingh , I H , Liem , M S L , de Meijer , V E , Patijn , G A , Festen , S , Stommel , M W J , Bosscha , K , Polée , M B , Nio , Y C , Wessels , F J , de Vries , J J J , van Lienden , K P , Bruijnen , R ....

مصطلحات موضوعية: Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Fluorouracil/therapeutic use, Follow-Up Studies, Humans, Irinotecan/therapeutic use, Leucovorin/therapeutic use, Male, Middle Aged, Neoplasm Staging, Netherlands/epidemiology, Oxaliplatin/therapeutic use, Pancreas/pathology, Pancreatectomy/methods, Pancreatic Neoplasms/diagnosis, Propensity Score, Prospective Studies, Survival Rate/trends, SURGERY, FOLFIRINOX, locally advanced pancreatic cancer, QUALITY-OF-LIFE, BORDERLINE, ADENOCARCINOMA, NEOADJUVANT THERAPY, resection, IMPACT, OUTCOMES

الإتاحة: https://doi.org/10.1097/SLA.0000000000005120Test
https://cris.maastrichtuniversity.nl/en/publications/f6b8a119-7f0f-45d2-a47a-8a2519257410Test

المؤلفون: Olusola Olusesan Faluyi, Emma Batman, Ian Chau, Debashis Sarker, David A Cairns, Mairéad G McNamara, Judith Cave, Nicholas S. Reed, Juan W. Valle, Helen Howard, Angela Lamarca, Jonathan Wadsley, R Hubner, Jayne Swain, Zoe Craig, Wasat Mansoor, Tim Meyer, Lucy Wall, Rohini Sharma

المصدر: Craig, Z, Swain, J, Batman, E, Wadsley, J, Reed, N, Faluyi, O, Cave, J, Rohini, S, Chau, I, Wall, L, Lamarca, A, Hubner, R, Mansoor, W, Sarker, D, Meyer, T, Cairns, D A, Howard, H, Valle, J & Mcnamara, M 2020, ' NET-02 trial protocol : A multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC) ', BMJ Open, vol. 10, no. 2, e034527, pp. e034527 . https://doi.org/10.1136/bmjopen-2019-034527Test
e034527
BMJ Open

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Irinotecan/therapeutic use, medicine.medical_treatment, liposomal irinotecan, Leucovorin, Irinotecan, Fluorouracil/therapeutic use, 1117 Public Health and Health Services, Folinic acid, Clinical Trials, Phase II as Topic, Quality of life, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Protocol, media_common.cataloged_instance, docetaxel, Humans, Multicenter Studies as Topic, European union, Etoposide, Docetaxel/therapeutic use, media_common, Randomized Controlled Trials as Topic, Carcinoma, Neuroendocrine/drug therapy, Chemotherapy, Leucovorin/therapeutic use, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, neuroendocrine carcinoma, 1103 Clinical Sciences, General Medicine, Carcinoma, Neuroendocrine, single-stage, Clinical trial, Docetaxel, Fluorouracil, Quality of Life, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business, randomised, medicine.drug, 1199 Other Medical and Health Sciences

وصف الملف: text; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ec48177b86e441f2cdf28923503289Test
https://eprints.soton.ac.uk/478146Test/

المؤلفون: Jakobsen, J N, Urup, T, Grunnet, K, Toft, A, Johansen, M D, Poulsen, S H, Christensen, I J, Muhic, A, Poulsen, H S

المصدر: Jakobsen , J N , Urup , T , Grunnet , K , Toft , A , Johansen , M D , Poulsen , S H , Christensen , I J , Muhic , A & Poulsen , H S 2018 , ' Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients ' , Journal of Neuro-Oncology , vol. 137 , no. 2 , pp. 439-446 . https://doi.org/10.1007/s11060-017-2736-xTest

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Immunological/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/toxicity, Bevacizumab/therapeutic use, Brain Neoplasms/drug therapy, Female, Follow-Up Studies, Glioblastoma/drug therapy, Humans, Irinotecan/therapeutic use, Lomustine/therapeutic use, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy, Salvage Therapy, Treatment Outcome, Young Adult

الإتاحة: https://doi.org/10.1007/s11060-017-2736-xTest
https://curis.ku.dk/portal/da/publications/toxicity-and-efficacy-of-lomustine-and-bevacizumab-in-recurrent-glioblastoma-patientsTest(9cb8e54c-5af3-4075-ba50-2dda6f469e38).html